With 35% ownership, Silence Therapeutics plc (NASDAQ:SLN) insiders have a lot at stake [Yahoo! Finance]
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth [Yahoo! Finance]
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth
Silence Therapeutics CEO Craig Tooman steps down [Seeking Alpha]
Silence Therapeutics Announces Leadership Changes [Yahoo! Finance]